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According to Hench et al. (1971), a material can be classiﬁed as
bioactive if it evokes a speciﬁc biological response that results
in bond formation between the material and a tissue (e.g.,
bone). Biomaterials were originally designed to be inert, and
the discovery of bioactive glasses by Hench initiated an excit-
ing new era in the ﬁeld. In SiO2, CaO, Na2O, and P2O5 sys-
tems, certain compositions were observed to resist removal
and to form a strong bond with the bone after implantation
(Hench and Wilson, 1993). These silicate-based bioactive
glasses have a high degree of biocompatibility, with calcium
and phosphorus in proportions identical to those of natural
bone. Bioactive glasses have also been used to bind to tooth
components (Hench, 2006).
The purpose of this review was to analyze the effect of ions
in the properties of bioactive glasses and to summarize their
major clinical applications in the ﬁeld of medicine and dentistry
reported in the literature. In preparing this review, all English-
language articles published between 1971 (the ﬁrst report of
bioactive glass) and 2013 were accessed electronically using
automated searches. The PubMed database and Google search
engine were searched with keywords, including: bioactive glass,
bioactive glass ions, clinical applications of bioactive glasses,
and bioactive glasses in medicine and dentistry. We reviewed
the abstracts of over 100 articles and short-listed 50 articles
and scientiﬁc proceedings on the basis of their relevance to
the review topic. Articles reporting similar ﬁndings were ex-
cluded. The ﬁnal articles were printed and studied in detail.
2. Effects of ions on the composition of bioactive glasses
The ﬁrst bioactive glass, Bioglass, was discovered by Hench.
The original formulation, commonly called 45S5, contained
45 wt.% SiO2, 24.5 wt.% Na2O and CaO, and 6 wt.% P2O5
(Kobayashi et al., 2010). Most current research focuses on
changing the structure of 45S5 by adding or removing ions
to make the material more compatible for different clinical
applications.
2.1. Effect of ﬂuoride
The addition of ﬂuoride can provide numerous advantages to
bioactive glasses and ceramics (Hench et al., 1988). Fluoride
prevents dental decay by inhibiting the demineralization of en-
amel and dentin, enhancing remineralization, and inhibiting
bacterial enzymes (Thuy et al., 2008). Fluoride also forms ﬂu-
orapatite (FAP) instead of carbonated hydroxyapatite, which
is more acid-resistant. Thus, adding ﬂuoride to bioactive glass
can improve oral health (Brauer et al., 2009).2.2. Effect of phosphate
Phosphate can be present in bioactive glasses as orthophos-
phate (Elgayar et al., 2005). When the bioactive glass is ex-
posed to body ﬂuids, a layer of hydroxycarbonate apatite is
formed (Wallace et al., 1999). Hydroxycarbonate apatite layer
signiﬁcantly increases the biocompatibility of these bioactive
glasses (Olmo et al., 2003). The resulting bioactive glass can
be used to treat dentin hypersensitivity (DH) by occluding den-
tinal tubules (Litkowski et al., 1997). However, FAP is supe-
rior to hydroxycarbonate apatite in terms of acid resistance
(Lynch et al., 2012). Increasing the P2O5 and cation contents
in ﬂuoride-containing glasses aids in maintaining the network
connectivity and favors the formation of FAP, rather than
ﬂuorite, with apatite also being formed at low pH. These con-
ditions (increasing P2O5 and cation content in ﬂuoride contain-
ing glasses) are more favorable for clinical applications of
dentistry and orthopedics (Brauer et al., 2010).
2.3. Effect of strontium
Strontium is a bone-seeking agent like calcium that is naturally
found in the liver, physiological ﬂuids, muscles, and bones
(Patrick et al., 1997). Strontium can favorably impact bone
cells. Strontium ranelate and strontium chloride have been
used in the treatment of osteoporosis (Dahl et al., 2001). Stron-
tium can be substituted for calcium in bioactive glass, resulting
in better bone bonding and osteoblast stimulation, with ana-
bolic and anti-catabolic properties (Fredholm el al., 2012).
Strontium-substituted Bioglass promotes osteoblast prolifer-
ation and decreases osteoclast activity in cell culture (Gentle-
man et al., 2010). Strontium in a silica-based dentifrice was
observed to be clinically effective in treating DH (Addy
et al., 1987).
2.4. Effect of zinc
Zinc can improve the ability of glass to bond with bone (Aina
et al., 2007). Zinc is a fundamental ion that controls cell
growth, differentiation, and development, but the biomechan-
ical mechanisms involved in these processes are not entirely
understood (Brandao et al., 1995). Zinc is essential for DNA
replication and stimulates protein synthesis (Tang et al.,
2001). Zinc deﬁciency slows skeletal growth and causes altera-
tions in bone calciﬁcation (Holloway et al., 1996). Zinc can
activate bone formation and inhibit bone resorption (Yamag-
uchi and Yamaguchi, 1986). Dentifrices with 2% zinc citrate
have been used in the treatment of poor gingival health, as they
have antiinﬂammatory and antimicrobial properties (Williams
et al., 1998).
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Bioactive glasses have a wide range of clinical applications in
both medicine and dentistry (Melek et al., 2013). The ﬁrst re-
ported clinical application of bioactive glass was the treatment
of conductive hearing loss for the reconstruction of the bony
ossicular chain of the middle ear (Greenspan, 1999). Bioactive
silicate glass has also been used for implant coatings, as a bone
graft (Towler et al., 2002), in dentifrices (Tai et al., 2006), and
as air-abrasive particles to remove carious enamel and dentin
(Farooq et al., 2012). Goudouri et al. (2011) indicated that bio-
active glass could be used as a dental material to improve the
bonding of the restorative material to dentin.
3.1. Application as a bone graft
Bone grafts can impact osteogenesis, osteoconduction, and
osteoinduction (Lindhe et al., 2008). Bioglass has been used
clinically as a synthetic bone graft material for over 10 years
under two different product names: Novabone for orthope-
dics (Ahmed, 2006) and Perioglass for maxillofacial surgery
(Fetner et al., 1994). Bioglass was approved by the US Food
and Drug Administration (FDA) in 2005 for osteostimulation
(Hench, 1998). It functions as an osteoconductive scaffold and
has an osteostimulatory effect (Boccaccini et al., 2010), which
traditional calcium phosphate and calcium sulfate osteocon-
ductive bioceramics do not have (Gerhardt and Boccaccini,
2010) (Table 1).
3.2. Application as a coating material for dental implants
Although hydroxyapatite can be sprayed on the surface of
dental implants as a bioactive coating material, its use has
unavoidable drawbacks (Eberhardt et al., 1992). Implant
coatings require good adherence to the metal substrate.Table 1 Comparison of HA/TCP and bioactive glasses as bone gra
HA and HA/TCP
Chemical
composition
One or two chemical
components (Hydroxya
tricalcium phosphate, o
Physical forms Porous blocks or granu
Basic
mechanism
Serves as osteoconduct
surface
Molecular
mechanism of
action in vivo
Not deﬁned
Regulation of
bioactivity
Based only on HA/TC
Resorption
rate
TCP is resorbed fast (m
HA is slowly/very slow
resorbed
Mechanism of
resorption
Involves chemical disso
and Osteoclastic resorp
Antimicrobial
properties
Not reportedTitanium implant surfaces are routinely coated with
hydroxyapatite to produce this rough surface and improve
osseointegration, but their adherence to the metal is not ideal
(Whitehead et al., 1993). Consequently, researchers have
studied components to improve physical compatibility with
titanium (Pazo et al., 1998). Bioglassmay be used as an alter-
nate osteoproductive, abrasive surface material for implants
(Koller et al., 2007). However, more research is needed for
bioactive glasses to be used clinically as a coating material
for dental implants.
3.3. Application as a disinfectant
Bioactive glasses can serve as topical endodontic disinfectants
with no effects on dentin stability (Doyon et al., 2005). Bioac-
tive glass can raise the pH of an aqueous environment to pro-
duce its antimicrobial effects (Allan et al., 2001). Bioglass
can also mineralize, which may be advantageous in endodon-
tics, but further research is required to support this idea. When
implanted in areas of periodontal defects, Bioglass can inhi-
bit bacterial colonization at the surgical site (Allan et al., 2002)
by increasing the pH and calcium levels (Allan et al., 2001).
Calcium hydroxide can be used as an intracanal dressing to
form a hard apical barrier in young, traumatized teeth, but
its alkaline nature can weaken the dentin structure by dissolv-
ing the acidic bonding agents in the organic dentin matrix
(Andreasen et al., 2002). Calcium hydroxide has a better anti-
microbial effect than bioactive glass (Zehnder et al., 2006).
3.4. Application in bone regeneration
Bioactive glass can promote bone regeneration, with osteo-
stimulatory effects in vitro (Hench, 2013). Similarly, in primate
models, bioactive glass ﬁlled bony defects by stimulating osteo-
production (Wilson et al., 1987). Felipe et al. (2009) reported
that bioactive glass particles were able to treat periodontalft substitutes (Valimaki and Aro, 2006).
Bioactive glasses
patite,
r both)
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Original; four-component system of SiO2, Na2O, CaO
and P2O5 Hench et al. (1971) (4). Modiﬁed system;
Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2 Brink et al.
(1997) (6)
les Granules or sintered porous blocks, ﬁbers and Woven
structures
ive Forms chemical bonding with ongrowing new Bone.
Osteopromotive
Induce high local bone turnover
P ratio Can be regulated by modifying the chemical
composition
onths)
ly
Resorption can be highly regulated [from weeks to
years] by modifying the chemical composition
lution
tion
Chemical dissolution
Inhibition of bacterial growth in vitro, dependent on
the chemical composition
Figure 1 SEM-micrographs showing dentine surface brushed with Novamin (with 45S5) toothpaste for 2 min demonstrating tubule
occlusion (Wang et al., 2010). (A) Bioactive glass particles on the dentine surfaces (at 1500·). (B) Bioactive glass particles embedded inside
the dentinal tubules (at 7500·).
4 S. Ali et al.defects and triggered the development of mineralized bone in
dogs.
3.5. Application in treating DH
The similarity between bone and dentin provides a rationale
for testing bioactive glass in treating DH (Lynch et al.,
2012). Bioglass 45S5, for example, can be used for reminer-
alizing dentifrices for DH treatment (Farooq et al., 2013)
(Fig. 1). However, there is no commercially available material
for treating DH via permanent blockade of the dentinal tu-
bules. Therefore, further research is needed to identify materi-
als that form intimate bonds with the tooth structure and
permanently block the tubules. Permanent bonding would re-
duce the incidence of dentinal tubule reopening resulting from
oral ﬂuid exposure.4. Conclusion
Bioactive glasses have many applications in dentistry and
medicine. Altering the composition of the bioactive glass by
adding different ions changes its suitability for speciﬁc
clinical applications. Considering the existing applications,
there is a strong rationale for additional use in medicine and
dentistry, and further research is needed to explore further
applications.Conﬂict of interest
The authors declare no conﬂict of interest.References
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